| Preface |
|
v | (5) |
| Contributors |
|
x | |
| Part I: Immunomodulation |
|
1 | (168) |
|
1. The Immune System and Immune Modulation |
|
|
1 | (20) |
|
|
|
|
|
|
|
|
|
|
|
2. Molecular Mechanisms Controlling Immunoglobulin E Responses |
|
|
21 | (14) |
|
|
|
|
|
|
|
|
|
|
|
3. Idiotypes and T Cell Selection |
|
|
35 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4. In Vivo Modulation of Lymphohemopoietic Stem Cell Populations with Cytokines |
|
|
55 | (20) |
|
|
|
|
|
|
|
|
|
|
|
5. Hormones as Immune Modulating Agents |
|
|
75 | (46) |
|
|
|
|
|
|
|
|
|
|
|
6. Transforming Growth Factor-BETA: A Cytokine Paradigm |
|
|
121 | (24) |
|
Michelle R. Frazier-Jessen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7. Psychological Stress and Immune Competence |
|
|
145 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8. Interleukin 12: A Potent Vaccine Adjuvant for Promoting Cellular Immunity and Modulating Humoral Immunity |
|
|
161 | (8) |
|
|
|
|
|
| Part II: Immunomodulating Agents in Disease |
|
169 | (216) |
|
9. Cytokine Immunomodulation of Infectious Diseases |
|
|
169 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10. Modulating Cytolytic Responses to Infectious Pathogens |
|
|
187 | (22) |
|
|
|
|
|
|
|
|
|
|
|
11. Immunology of T Cells in AIDS: Dynamics Revealed by Eight-Color Flow Cytometry |
|
|
209 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12. Immunomodulation of Schistosomal-Induced Inflammation |
|
|
221 | (16) |
|
|
|
|
|
|
13. Human Monoclonal Antibodies and Immune Modulation in Viral Hepatitis, Schistosomiasis, and HTLV Infection |
|
|
237 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14. Nutrition and Immunity |
|
|
255 | (12) |
|
|
|
|
|
|
|
|
|
|
|
15. Immunomodulating Agents in Gastrointestinal Disease |
|
|
267 | (34) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16. Immune Modulation in Sepsis |
|
|
301 | (44) |
|
|
|
|
|
|
|
|
|
|
|
17. Interleukin 6: Role in the Pathogenesis of Cancer |
|
|
345 | (18) |
|
|
|
|
|
|
18. Neuroendocrine-Induced Immune Modulation and Autoimmunity |
|
|
363 | (22) |
|
|
|
|
|
|
|
|
|
|
| Part III: Immunomodulating Agents in Therapy |
|
385 | (166) |
|
19. Antigen Delivery Systems Used to Induce Immunomodulation |
|
|
385 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20. Immunomodulation in Gene Therapeutics |
|
|
421 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21. Cytokines, Apoptosis, and Immune Therapy in HIV Infection |
|
|
439 | (18) |
|
|
|
|
|
|
|
|
|
|
|
22. Host-Directed and Immune-Based Therapies for Human Immunodeficiency Virus Infection |
|
|
457 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23. Transplantation Tolerance, Microchimerism, and the Two-Way Paradigm |
|
|
483 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24. Immunomodulation of Cytokines and T Cells by Biologicals in Rheumatoid Arthritis |
|
|
507 | (22) |
|
|
|
|
|
|
|
|
|
|
|
25. Immunomodulation at Mucosal Surfaces: Prospects for the Development of Antiinfectious and Antiinflammatory Vaccines |
|
|
529 | (10) |
|
|
|
|
|
|
|
|
|
|
|
26. New Statistical Designs for Clinical Trials of Immunomodulating Agents |
|
|
539 | (12) |
|
|
|
|
|
| Index |
|
551 | |
Shopping Cart
